José R Zanchetta Selected Research

Pharmaceutical Preparations

1/2007

Tolerability of intravenous pamidronate for the treatment of osteoporosis and other metabolic osteopathies: A retrospective analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José R Zanchetta Research Topics

Disease

7	Osteoporosis 10/2016 - 11/2004
4	Postmenopausal Osteoporosis 10/2016 - 05/2006
2	Celiac Disease (Celiac Sprue) 01/2018 - 01/2017
1	Hypercalciuria 06/2010
1	Muscle Cramp (Cramp) 12/2008
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Renal Insufficiency (Renal Failure) 01/2007
1	Multiple Myeloma 01/2007
1	Bone Resorption 05/2006
1	Breast Neoplasms (Breast Cancer) 11/2004

Drug/Important Bio-Agent (IBA)

2	Parathyroid Hormone (Parathormone)IBA 11/2010 - 05/2006
2	Raloxifene Hydrochloride (Evista)FDA Link 12/2008 - 11/2004
1	Denosumab FDA Link 10/2016
1	abaloparatideIBA 02/2015
1	Peptides (Polypeptides)IBA 02/2015
1	Parathyroid Hormone-Related ProteinIBA 02/2015
1	N 30IBA 06/2010
1	bazedoxifeneIBA 12/2008
1	Risedronic Acid (Actonel)FDA LinkGeneric 01/2008
1	Pharmaceutical PreparationsIBA 01/2007
1	Pamidronate (Aredia)FDA LinkGeneric 01/2007
1	Bone Density Conservation AgentsIBA 05/2006
1	Teriparatide (Parathar)FDA Link 05/2006

Therapy/Procedure

3	Therapeutics 02/2015 - 11/2004
2	Gluten-Free Diet 01/2018 - 01/2017
1	Contraindications 01/2007